Astrazeneca (AZN) Debt Ratio (2009 - 2026)
Astrazeneca (AZN) posted quarterly Debt Ratio of 0.25 for Q2 2026, down 8.28% year-over-year from 0.28 in Q2 2025, and up 157.6% quarter-over-quarter from 0.44 in Q1 2026.
Astrazeneca (AZN) Debt Ratio (2009 - 2026) Analysis & Trends
Astrazeneca's Debt Ratio history runs 18 years deep, the most recent figure standing at 0.25 for Q2 2026.
- In Q2 2026, Debt Ratio fell 8.28% year-over-year to 0.25; the TTM figure through Jun 2026 stood at 0.25 (down 8.28% YoY), while the FY2025 annual figure was 0.24, down 12.04% from the prior year.
- Debt Ratio for Q2 2026 stood at 0.25, up from 0.44 in the prior quarter.
- The five-year high for Debt Ratio was 87.84 in Q4 2023, with the low at 0.54 in Q1 2023.
- The 5-year median for Debt Ratio is 0.44 (2026), against an average of 5.65.
- The sharpest annual moves came in 2022 and 2023: Debt Ratio plunged 99.9% in 2022, then surged 29869.56% in 2023.
- Astrazeneca's Debt Ratio stood at 0.29 in 2022, then soared by 29869.56% to 87.84 in 2023, then plunged by 99.68% to 0.28 in 2024, then slipped by 12.04% to 0.24 in 2025, then climbed by 4.4% to 0.25 in 2026.
- Business Quant data shows AZN's Debt Ratio at 0.25 in Q2 2026, 0.44 in Q1 2026, and 0.24 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.90 Bn | 633.14 Bn | 17.26 Bn | 0.24 |
| 2 | AbbVie | 470.19 Bn | 463.62 Bn | 12.70 Bn | 0.52 |
| 3 | Merck | 377.19 Bn | 370.05 Bn | 12.21 Bn | 0.42 |
| 4 | Novartis Ag | 303.28 Bn | 295.59 Bn | 11.24 Bn | 0.08 |
| 5 | Astrazeneca | 257.67 Bn | 252.77 Bn | 12.86 Bn | 0.25 |
| 6 | Amgen | 236.95 Bn | 222.96 Bn | 7.24 Bn | 0.66 |
| 7 | Gilead Sciences | 182.20 Bn | 179.02 Bn | 6.22 Bn | 0.58 |
| 8 | Pfizer | 159.32 Bn | 147.62 Bn | 10.94 Bn | 0.31 |
| 9 | Gsk | 106.10 Bn | 101.93 Bn | 8.24 Bn | -0.31 |
| 10 | Sanofi | 55.07 Bn | 47.69 Bn | 10.79 Bn | 0.17 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.25 |
| Mar 31, 2026 | -0.44 |
| Dec 31, 2025 | 0.24 |
| Sep 30, 2025 | -0.43 |
| Jun 30, 2025 | 0.28 |
| Mar 31, 2025 | -0.50 |
| Dec 31, 2024 | 0.28 |
| Sep 30, 2024 | -0.53 |
| Mar 31, 2024 | -0.53 |
| Dec 31, 2023 | 87.84 |
| Sep 30, 2023 | -0.47 |
| Mar 31, 2023 | -0.54 |
| Dec 31, 2022 | 0.29 |
| Sep 30, 2022 | -0.50 |
| Mar 31, 2022 | -0.53 |
| Dec 31, 2021 | 286.48 |
| Sep 30, 2021 | -0.49 |
| Mar 31, 2021 | -0.46 |
| Dec 31, 2020 | -0.44 |
| Sep 30, 2020 | -0.50 |